These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22165697)

  • 1. [Modern technologies in diabetology. CSII (continuous subcutaneous insulin infusion) and CGM (continuous glucose monitoring) in clinical practice].
    Olsovský J
    Vnitr Lek; 2011 Nov; 57(11):919-22. PubMed ID: 22165697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose monitoring and pump data management software operated on a personal digital assistant can contribute to improve diabetes control in CSII-treated patients.
    Boizel R; Benhamou PY; Renard E;
    Diabetes Metab; 2007 Sep; 33(4):314-5. PubMed ID: 17475533
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of young infants presenting neonatal diabetes mellitus with continuous subcutaneous insulin infusion before genetic diagnosis.
    Rabbone I; Barbetti F; Marigliano M; Bonfanti R; Piccinno E; Ortolani F; Ignaccolo G; Maffeis C; Confetto S; Cerutti F; Zanfardino A; Iafusco D
    Acta Diabetol; 2016 Aug; 53(4):559-65. PubMed ID: 26831749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of self monitoring of blood glucose (SMBG) and continuous subcutaneous insulin infusion (CSII) in diabetic pregnant women].
    Murata K; Toyoda N; Ito M; Rii T; Sugiyama Y; Miyamura Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2749-57. PubMed ID: 4086905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of technology in diabetes therapy.
    Ginsberg BH
    Diabetes Care; 1994 Jun; 17 Suppl 1():50-5. PubMed ID: 8088225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
    Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L
    Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus].
    Pfützner A; Berger S; Spinas G
    Schweiz Med Wochenschr; 2000 Dec; 130(48):1854-61. PubMed ID: 11132530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control.
    Radermecker RP; Renard E; Scheen AJ
    Diabetes Metab Res Rev; 2009 Sep; 25(6):491-501. PubMed ID: 19496088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical methods for the retrieval and interpretation of continuous glucose monitoring data in diabetes.
    Kovatchev B; Breton M; Clarke W
    Methods Enzymol; 2009; 454():69-86. PubMed ID: 19216923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No apparent local effect of insulin on microdialysis continuous glucose- monitoring measurements.
    Hermanides J; Wentholt IM; Hart AA; Hoekstra JB; DeVries JH
    Diabetes Care; 2008 Jun; 31(6):1120-2. PubMed ID: 18332157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluating the feature of hypoglycemia detected by continuous glucose monitoring system during temporary continuous subcutaneous insulin infusion in type 2 diabetes patients].
    Li M; Zhou J; Bo YQ; Lu W; Jia WP; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1679-82. PubMed ID: 19024537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained metabolic control and low rates of severe hypoglycaemic episodes in preschool diabetic children treated with continuous subcutaneous insulin infusion.
    Pańkowska E; Szypowska A; Lipka M; Skórka A
    Acta Paediatr; 2007 Jun; 96(6):881-4. PubMed ID: 17537017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Implantable artificial endocrine pancreas].
    Shichiri M; Nishida K; Sakakida M; Araki E
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():620-4. PubMed ID: 12387060
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term clinical application of wearable artificial endocrine pancreas].
    Sakakida M; Nishida K; Shimoda S; Matsuo Y; Araki E; Shichiri M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():613-9. PubMed ID: 12387059
    [No Abstract]   [Full Text] [Related]  

  • 17. Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring.
    De Block C; Manuel-Y-Keenoy B; Van Gaal L; Rogiers P
    Diabetes Care; 2006 Aug; 29(8):1750-6. PubMed ID: 16873775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fulfilling the promise of insulin pump therapy in childhood diabetes.
    Tamborlane WV
    Pediatr Diabetes; 2006 Aug; 7 Suppl 4():4-10. PubMed ID: 16774611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New methods in insulin treatment].
    Neuwirth G
    Orv Hetil; 2005 Jan; 146(3):111-6. PubMed ID: 15693442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin-dependent diabetes mellitus: subcutaneous insulin therapy with a portable infusion pump].
    Tresánchez Trías JM; Mesa Manteca J; Sanmartí Sala AM; Obiols Alfonso G; Pujol Borrell R
    Med Clin (Barc); 1983 Mar; 80(9):394-7. PubMed ID: 6855331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.